| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c20933 _d20933 |
||
| 001 | BD-DhNSU-20933 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403064321.0 | ||
| 008 | 190403s2003 ukna|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a0896039633 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRC271 _b.C5N476 2003 |
| 245 | 0 | 0 |
_aNovel anticancer drug protocols / _cedited by John K. Buolamwin and Alex A. Adjei |
| 260 |
_aTotowa, NJ : _bHumana Press, _cc2003. |
||
| 300 |
_axv, 355 p. : _bill. ; _c24 cm. |
||
| 490 | 1 | _aMethods in molecular medicine ; 85 | |
| 650 | 0 | _aAntineoplastic agents | |
| 650 | 4 | _aResearch | |
| 650 | 4 | _aMethodology | |
| 700 | 1 | _aBuolamwin, John K. | |
| 700 | 1 | _aAdjei, Alex A. | |
| 942 |
_2lcc _cBK |
||